Mepidont 2% with adrenaline 1: 100,000, L.Molteni & C.dei F.lli Alitti Societa di Esercizio
indications:
All conservative and surgical procedures in dentistry in cases where it is desired to achieve local anesthesia with prolonged duration or when it is necessary to achieve the state of local anemization.
Composition:
1 ml of solution contains 20 mg of mepivacaine hydrochloride and 0.01 mg adrenaline in the form of tartrate.
Action:
Contraindications:
Hypersensitivity to the active substance or to any of the excipients. The use of vasoconstrictor is not recommended in people with severe cardiac and peripheral artery disease, hypertension, migraine, hyperthyroidism, diabetes, prostatic hypertrophy, narrow-angle glaucoma and nephropathy.
Precautions:
Pregnancy and lactation:
Do not use during pregnancy.
Side effects:
The following toxic effects have been reported as a result of overdose: agitation o.u.n. with the state of excitement, tremor, confusion, dizziness, dilated pupils, accelerated metabolism and increased body temperature; after very large doses: lockjaw and convulsions. In the case of prolonged medication, the cardiovascular, respiratory and emetic medium is stimulated, resulting in sweating, arrhythmias, hypertension, increased breathing, bronchiectasis, nausea and vomiting. Peripheral effects of the drug on the cardiovascular system include bradycardia and dilation of blood vessels. Very rarely, the preparation may cause sensitization in the form of skin lesions, urticaria, edema or anaphylactic shock. The vasoconstrictor may cause the following reactions, especially in people with cardiovascular disease: anxiety, sweating, breathing problems, arrhythmias, hypertension (which may be a serious condition in patients with established hypertension and in patients with hyperthyroidism) ), severe headache, photophobia, retrosternal pain, vomiting.
Dosage:
1-2 ml or more, depending on the needs of the surgery, infiltrating or blocking the peripheral nerve. The anesthetic solution should be injected in small doses at a rate of about 1 ml / min after prior aspiration. In a healthy adult who has not received sedatives, the maximum dose administered once or in several consecutive injections over a period of no more than 90 minutes is 7 mg mepivacaine hydrochloride / kg body weight, up to a total dose of 550 mg of mepivacaine hydrochloride and 0.2 mg adrenaline. The maximum dose is 1000 mg mepivacaine / 24 h. In children, the doses given should be reduced depending on body weight and age.
(C)
